---
title: "Zhaoke Ophthalmology Wins NMPA Approval for Cyclosporine Eye Gel"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305450070.md"
description: "Zhaoke Ophthalmology received NMPA marketing approval for its cyclosporine ophthalmic gel to treat dry eye disease on November 10, 2026. The company published the original content via the Hong Kong Stock Exchange's regulatory disclosure system on November 13, 2026."
datetime: "2026-11-13T10:42:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305450070.md)
  - [en](https://longbridge.com/en/news/305450070.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305450070.md)
generator: "portal-rs"
---

# Zhaoke Ophthalmology Wins NMPA Approval for Cyclosporine Eye Gel

-   Zhaoke Ophthalmology’s cyclosporine ophthalmic gel received National Medical Products Administration marketing approval for dry eye disease on November 10, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhaoke Ophthalmology Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261113-12412510), on November 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [06622.HK](https://longbridge.com/en/quote/06622.HK.md)

## Related News & Research

- [Tesla’s Cheapest Model Y Gets More Range in the U.S., But Not in Canada](https://longbridge.com/en/news/305577641.md)
- [Vishnusurya Projects and Infra's (NSE:VISHNUINFR) Weak Earnings May Only Reveal A Part Of The Whole Picture](https://longbridge.com/en/news/305559929.md)
- [Pondy Oxides And Chemicals Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected](https://longbridge.com/en/news/305560101.md)
- [Here's What Analysts Are Forecasting For Yue Yuen Industrial (Holdings) Limited (HKG:551) After Its Third-Quarter Results](https://longbridge.com/en/news/305557807.md)
- [Alkem Laboratories Limited (NSE:ALKEM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates](https://longbridge.com/en/news/305559747.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**